PHRRF   $0.103  3.00% Market Closed

PHARMATHER HLDGS LTD
Last Events:

2023-08-09 Trend pattern changed from расходящийся клин с наклоном вверх to сужающийся канал.

2023-08-09 Signal in MACD changed from bullish to bullish weakening. Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: up-crossing the middle level.

2023-08-09 Signal in RSI changed from bullish weakening to bearish. RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

2023-08-09 Signal in EMA20 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-08-06 Trend pattern changed from расходящийся треугольник to расходящийся клин с наклоном вверх.

2023-08-06 Signal in MACD changed from bearish weakening to bullish. Oscillator MACD is in the positive territory it's lower than the signal line and it crossed the zero line from the bottom. These factors mean that there is probably a growing trend. Last signal: up-crossing the middle level.

2023-08-06 Signal in RSI changed from bullish to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: exit from the overbought zone.

2023-08-04 Signal in Stochastic changed from bullish reversal to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.


Current temperature: 0.00
ST: 0, Cor:

50-50 Year Forecast
Low with 48% probability: 0.11
Target: 3.75
High with 44% probability: 1.24
Analyst Recommendations:
Number of estimates 1
Target Price Mean 3.75
Mean unverified/preliminary 3.75 / 3.75
Target Price Low / High 3.75 / 3.75
Median / STD DEV 3.75 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None Sell Sell
rsi ActivelyBuy Sell Sell
macd None None None
stoch None None None
ma20 Buy Sell Sell
ma50 None None None
ma100 None None None
Candlestick PatternAug. 18, 2023 Bullish Three Inside Up - pattern is a made up of three candlesticks. Big black candlestick appears on the first day in a downtrend. The second day body is engulfed by the body of the first day. A white candlestick on the third day with a higher close than the second day. Considered to be a bullish reversal pattern.
ISIN CA71716H1082
ceo Mr. Fabio Chianelli
Website https://www.pharmather.com
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.